Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07117162 · ClinicalTrials.gov registry record · NA

Improving Access to Care for Veterans With Memory Loss

A NA study of Alzheimer Disease, sponsored by VA Pittsburgh Healthcare System.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07117162 is a NA study of Alzheimer Disease that is actively recruiting participants, run by VA Pittsburgh Healthcare System. The registered enrollment target is 30 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07117162, a NA study of Alzheimer Disease, is actively recruiting participants, sponsored by VA Pittsburgh Healthcare System.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advanced diagnostics, and streamlined workflows to expedite screening for eligibility for amyloid targeting therapies.

Conditions Studied

Interventions

  • OTHER ADRD Care Delivery Protocol

Study Locations (1)

Pennsylvania

  • VA Pittsburgh Healthcare System - Pittsburgh

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-10-29
Est. Completion 2027-06
Phase NA

Sponsor

VA Pittsburgh Healthcare System

17 total trials

What the Registry Record Tells You About NCT07117162

The ClinicalTrials.gov registry entry for NCT07117162 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is VA Pittsburgh Healthcare System, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which ADRD Care Delivery Protocol is the first listed.

NCT07117162 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07117162 about?

NCT07117162 is a clinical study titled "Improving Access to Care for Veterans With Memory Loss". This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates...

What is the current status of trial NCT07117162?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-10-29. Estimated completion is 2027-06.

What conditions does trial NCT07117162 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT07117162?

The interventions under investigation include: ADRD Care Delivery Protocol (OTHER).

Who is sponsoring clinical trial NCT07117162?

This trial is sponsored by VA Pittsburgh Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07117162 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.